John T Cavan Insider Trading $HEPA Hepion Pharmaceuticals, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for John T Cavan.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of John T Cavan. John T Cavan is CFO in ContraVir Pharmaceuticals, Inc. ($CTRV) and Chief Financial Officer in ContraVir Pharmaceuticals, Inc. ($CTRV).
John T Cavan in Hepion Pharmaceuticals, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of John T Cavan: CFO, Chief Financial Officer
Holdings: 4,800 shares
Current Value: $6,720
Latest Transaction: Nov 30 2020
$HEPA Market Capitalization: $85.72M
$HEPA Previous Close: $1.40
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of John T Cavan in Hepion Pharmaceuticals, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 30 2020 | CTRV | Hepion Pharmaceuti ... | Cavan John T | Chief Financial Off ... | Buy | P | 1.62 | 4,500 | 7,290 | 4,800 | 300 to 4.8 K (+1,500.00 %) |
| Aug 21 2020 | CTRV | Hepion Pharmaceuti ... | Cavan John T | Chief Financial Off ... | Option Exercise | A | 3.72 | 160,000 | 595,200 | 381,060 | |
| Apr 07 2020 | CTRV | Hepion Pharmaceuti ... | Cavan John T | Chief Financial Off ... | Option Exercise | A | 1.63 | 215,000 | 350,450 | 221,059 | |
| Jul 25 2019 | CTRV | Hepion Pharmaceuti ... | Cavan John T | Chief Financial Off ... | Option Exercise | A | 3.24 | 5,820 | 18,857 | 6,059 | |
| Jul 03 2018 | CTRV | ContraVir Pharmace ... | Cavan John T | CFO | Option Exercise | P | 1.55 | 8,625 | 13,369 | 8,625 | |
| Jul 03 2018 | CTRV | ContraVir Pharmace ... | Cavan John T | CFO | Option Exercise | P | 1.55 | 15 | 23 | 15 | |
| Jan 05 2018 | CTRV | ContraVir Pharmace ... | Cavan John T | CFO | Grant | A | 0.00 | 101,221 | 0 | 167,947 | 66.7 K to 167.9 K (+151.70 %) |
| Jul 21 2017 | CTRV | ContraVir Pharmace ... | Cavan John T | Chief Financial Off ... | Option Exercise | A | 0.58 | 15,000 | 8,700 | 133,688 | |
| Jul 07 2017 | CTRV | ContraVir Pharmace ... | Cavan John T | CFO | Grant | A | 0.00 | 46,726 | 0 | 66,726 | 20 K to 66.7 K (+233.63 %) |
| Jun 22 2017 | CTRV | ContraVir Pharmace ... | Cavan John T | CFO | Buy | P | 0.65 | 20,000 | 13,000 | 20,000 | 0 to 20 K |
| Aug 29 2016 | CTRV | ContraVir Pharmace ... | Cavan John T | Chief Financial Off ... | Option Exercise | A | 1.10 | 18,688 | 20,557 | 118,688 |
Page: 1